| |
|
2000 - Abstracts, References, and PDFs
|
|
Top
|
|
Vol. 37
|
|
October, Supplement 7 October 2000, p1
|
|
Monoclonal Antibody Therapy for Hematologic Malignancies: Prospects for an Integrated Therapy Approach
|
|
October, Supplement 6 October 2000, p1
|
|
Anemia: Where Are We Now; Where Are We Going? Clinical Consequences and Treatment Benefits
|
|
October October 2000 No. 4, p315
|
|
Cytogenetics in Hematologic Malingies
|
|
July, Supplement 5 July 2000, p1
|
|
New Frontiers in Deep Vein Thrombosis Management
|
|
July July 2000 No. 3, p219
|
|
Idiopathic Thrombocytopenic Purpura
|
|
April, Supplement 4 April 2000, p1
|
|
Clinical Issues and Treatment Advances in Thrombocytopenia
|
|
April April 2000 No. 2, p111
|
|
BLood Group Antigens: Molecular Biology, Functions, and Clinical Applications
|
|
January, Supplement 3 January 2000, p1
|
|
Thalidomide Therapy for Hematologic Malignancies
|
|
January, Supplement 2 January 2000, p1
|
|
The Biologic Basis of Stem-Cell Therapy
|
|
January, Supplement 1 January 2000, p1
|
|
Splenctomy-sparing strategies for the treatment and long-term maintenance of chronic immune thrombocytopenic purpura
|
|
January January 2000 No. 1, p1
|
|
Acquired Aplastic Anemias
|
|
| |
|
|
